Antiviral drugs such as Remdesivir (Veklury), Nirmatrelvir with Ritonavir (Paxlovid),
Azvudine, and Molnupiravir (Lagevrio) can reduce the risk for severe and fatal Coronavirus …

Patients with chronic kidney disease (CKD), including dialysis and transplant patients, are at
greater risk of contracting SARS‐CoV‐2 due to kidney dysfunction and preexisting …

Over 2 years have passed since the start of the COVID-19 pandemic, which has claimed
millions of lives. Unlike the early days of the pandemic, when management decisions were …

Abstract Coronavirus disease 2019 (COVID-19) caused by 2019 novel coronavirus (2019-
nCoV) has caused significant mortality and has been declared as a global pandemic by the …

Abstract Introduction In December 2019, an outbreak of a novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) began, resulting in a number of antivirals and …

Department of Nephrology, Cliniques Universitaires Saint-Luc, Av. Hippocrate 10, Brussels
1200, Belgium. E-mail: laura. labriola@ uclouvain. be ORCID: https://orcid. org/0000-0003 …

Abstract Coronavirus disease 2019 (COVID-19) is now a pandemic and its death toll is
rocketing up. Patients with acute kidney injury (AKI) and chronic kidney disease (CKD) are at …

Background Acute kidney injury (AKI) is an independent risk factor for mortality, which affects
about 5% of hospitalized coronavirus disease-2019 (COVID-19) patients and up to 25–29 …

Background Chronic kidney disease (CKD) is an important risk factor for mortality from
COVID-19. Remdesivir has been shown to shorten time to recovery in patients with severe …

The new coronavirus disease 2019 (COVID-19) has become a world health emergency. The
disease predominantly effects individuals between 30 and 79 years of age with 81% of …